Steward Partners Investment Advisory, LLC Halozyme Therapeutics, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $10.9 Billion
- Q1 2025
A detailed history of Steward Partners Investment Advisory, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 544 shares of HALO stock, worth $26,628. This represents 0.0% of its overall portfolio holdings.
Number of Shares
544
Previous 500
8.8%
Holding current value
$26,628
Previous $23,000
47.83%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding HALO
# of Institutions
587Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$862 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$628 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$296 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$191 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$180 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $6.82B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...